198 related articles for article (PubMed ID: 23636109)
1. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers.
Summers EM; Bingham CS; Dahle KW; Sweeney C; Ying J; Sontheimer RD
JAMA Dermatol; 2013 Jul; 149(7):814-8. PubMed ID: 23636109
[TBL] [Abstract][Full Text] [Related]
2. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study.
Joly P; Benoit-Corven C; Baricault S; Lambert A; Hellot MF; Josset V; Barbaud A; Courville P; Delaporte E; Collet E; Carvalho P; Modeste-Duval AB; Lacour JP; L'Anthoën-Arditi MH; Thuillez C; Benichou J
J Invest Dermatol; 2007 Dec; 127(12):2766-71. PubMed ID: 17713574
[TBL] [Abstract][Full Text] [Related]
3. Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
Vena GA; Cassano N; Coco V; De Simone C
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):447-50. PubMed ID: 23672527
[TBL] [Abstract][Full Text] [Related]
4. A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals.
Summers EM; Blickenstaff NR; Coman GC; Martins TB; Hill HR; Sontheimer RD
Ann Transl Med; 2017 Oct; 5(20):393. PubMed ID: 29152493
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA).
Shahin TB; Sreekantaswamy SA; Hawkes JE; Butler DC
Am J Clin Dermatol; 2023 May; 24(3):405-418. PubMed ID: 36920748
[TBL] [Abstract][Full Text] [Related]
6. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging.
Brummer GC; Wang LT; Sontheimer RD
Dermatol Online J; 2018 Feb; 24(2):. PubMed ID: 29630150
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive drugs and the risk of incident rosacea.
Spoendlin J; Voegel JJ; Jick SS; Meier CR
Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
[TBL] [Abstract][Full Text] [Related]
8. Intractable pruritus with chronic eczema in an elderly patient caused by long-term intake of calcium channel blocker.
Yoo J; Jue MS
Contact Dermatitis; 2017 Nov; 77(5):339-340. PubMed ID: 29063690
[No Abstract] [Full Text] [Related]
9. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse reactions to calcium channel blockers.
Tuchinda P; Kulthanan K; Khankham S; Jongjarearnprasert K; Dhana N
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):246-50. PubMed ID: 25268343
[TBL] [Abstract][Full Text] [Related]
11. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
[No Abstract] [Full Text] [Related]
12. The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort Study.
Hopkins AM; Lerner K; Grinich E; Ahn J; Choi Y; Hanifin J; Simpson E
Dermatitis; 2023; 34(5):419-424. PubMed ID: 37172272
[No Abstract] [Full Text] [Related]
13. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.
Caldarola G; Pirro F; Di Stefani A; Talamonti M; Galluzzo M; D'Adamio S; Magnano M; Bernardini N; Malagoli P; Bardazzi F; Potenza C; Bianchi L; Peris K; De Simone C
Expert Opin Biol Ther; 2020 Jun; 20(6):665-672. PubMed ID: 32045273
[No Abstract] [Full Text] [Related]
14. Eczematous Drug Eruptions.
Blum AE; Burgin S
Am J Clin Dermatol; 2021 May; 22(3):349-366. PubMed ID: 33587283
[TBL] [Abstract][Full Text] [Related]
15. Treatment of paradoxical eczematous eruption in psoriasis treated with secukinumab: A case report.
Xiao Y; Peng S; Li X; Mao T; Fang M; Hu Y; Ye W
Medicine (Baltimore); 2023 Feb; 102(6):e32844. PubMed ID: 36820537
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous adverse reactions associated with calcium channel blockers.
Stern R; Khalsa JH
Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic Generalized Exfoliative Dermatitis and Association with Antihypertensive Drugs and Statins: A Retrospective Case-Control Study.
Cheong KW; Yew YW; Tey HL
Dermatology; 2019; 235(2):107-111. PubMed ID: 30716732
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
19. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Özkaya E
Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers and beta-blockers in relation to Parkinson's disease.
Ton TG; Heckbert SR; Longstreth WT; Rossing MA; Kukull WA; Franklin GM; Swanson PD; Smith-Weller T; Checkoway H
Parkinsonism Relat Disord; 2007 Apr; 13(3):165-9. PubMed ID: 17055323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
